Paroxetine
anxiety disorders.The anxiety disorders for which Parogen is used are: obsessive-compulsive disorder (recurring, obsessive thoughts and uncontrollable behavior), panic disorder (panic attacks, including those caused by agoraphobia, i.e., fear of open spaces), social anxiety disorder (fear or avoidance of social situations), post-traumatic stress disorder (anxiety caused by a traumatic event), and generalized anxiety disorder (feeling of general, intense anxiety and nervousness).
Parogen belongs to a group of medicines called SSRIs (selective serotonin reuptake inhibitors). Each person has a substance called serotonin in their brain. In people with depression or anxiety, the level of serotonin is lower than in others. It is not fully understood how Parogen and other SSRIs work, but they may work by increasing the level of serotonin in the brain. Proper treatment of depression or depressive disorders is important for improving health and well-being.
In any of the above situations, the patient should tell their doctor before taking Parogen.
Before starting Parogen, the patient should discuss the following with their doctor, pharmacist, or nurse:
Parogen should not be used in children and adolescents under 18 years old.Patients under 18 years old are at increased risk of side effects such as suicidal attempts, suicidal thoughts, and hostility (mainly aggression, oppositional behavior, and anger) when taking this medicine. However, the doctor may prescribe Parogen to a patient under 18 years old if they consider it to be in the patient's best interest. If the doctor has prescribed Parogen to the patient (or their child) and the patient wants to discuss this, they should consult their doctor again. The patient should inform their doctor if they (or their child) experience any of the above symptoms while taking Parogen. Additionally, the long-term safety of Parogen in this age group, in terms of its effects on growth, maturation, intellectual and behavioral development, has not been established.
In studies in patients under 18 years old, some patients experienced withdrawal symptoms when stopping paroxetine. These symptoms were very similar to those seen in adults when stopping paroxetine (see section 3 "How to take Parogen").
During depression and/or anxiety, patients may sometimes experience thoughts of self-harm or suicide. These thoughts may worsen at the start of the first treatment with antidepressants, as the effect of these medicines may not be seen immediately, usually after a few weeks or longer.
If such thoughts occur at any time, the patient should contact their doctor or go to the hospital immediately.
Talking to a friend or family member about their depression or anxietyand asking them to read this leaflet may be helpful. They can be asked to tell the doctor if they think the patient's depression or anxiety is getting worse or if they notice any changes in the patient's behavior.
If the patient has any concerns, they should discuss them with their doctor.
In some patients taking paroxetine, a condition called akathisia may develop, in which the patient feels restless and cannot sit or stand still.
In other patients, a condition called serotonin syndrome may develop, with symptoms such as confusion, restlessness, sweating, shaking, shivering, hallucinations (strange visions or sounds), sudden muscle contractions, or rapid heartbeat. If the patient experiences any of these symptoms, they should contact their doctor immediately. More information about these and other side effects of Parogen can be found in section 4 "Possible side effects".
Medicines like Parogen (SSRIs or SNRIs) may cause sexual dysfunction (see section 4). In some cases, these symptoms have persisted after stopping treatment.
The patient should tell their doctor or pharmacist about all medicines they are taking, have recently taken, or might take.
Some medicines may affect the way Parogen works or increase the risk of side effects. Parogen may also affect the way other medicines work. These medicines include:
The patient should tell their doctor or pharmacist if they are taking, have recently taken, or might take any other medicines.
The patient should not drink alcohol while taking Parogen. Alcohol may increase the risk of side effects. Taking Parogen in the morning, with food, may reduce the risk of nausea.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a baby, they should consult their doctor or pharmacist before taking this medicine.
Paroxetine should not be used during pregnancy, as it may harm the baby. The patient and their doctor can decide whether to change the medicine or stop taking Parogen during pregnancy. However, depending on the circumstances, the doctor may consider it better for the patient to continue taking Parogen.
The patient should inform their midwife and/or doctor that they are taking Parogen.Medicines like Parogen taken during pregnancy, especially in the last 3 months, may increase the risk of a serious condition called persistent pulmonary hypertension in the newborn (PPHN), which causes rapid breathing and bluish skin in the baby. These symptoms may occur in the first 24 hours after birth. If they occur in the baby, the patient should contact their midwife and/or doctor immediately.
Symptoms include:
If the baby experiences any of these symptoms after birth, or if the patient has concerns about their baby's health, they should contact their doctor or midwife for advice.
Taking Parogen at the end of pregnancy may increase the risk of serious bleeding from the vagina, which occurs shortly after delivery, especially if the patient has a history of bleeding disorders. If the patient is taking Parogen, they should inform their doctor or midwife so that they can provide appropriate advice.
Parogen may pass into breast milk in very small amounts. If the patient is breastfeeding, they should consult their doctor before starting to breastfeed.
In animal studies, paroxetine has been shown to reduce sperm quality. This could theoretically affect fertility, but no effect on fertility has been seen in humans so far.
Parogen may cause side effects such as dizziness, confusion, drowsiness, and blurred vision. If these symptoms occur, the patient should not drive or operate machinery.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is essentially "sodium-free".
The patient should always take this medicine exactly as their doctor or pharmacist has told them. If they are unsure, they should ask their doctor or pharmacist.
The recommended doses for the various disorders are listed in the table below.
Depression
20 mg
20 mg
50 mg
Obsessive-compulsive disorder
20 mg
40 mg
60 mg
Panic disorder
10 mg
40 mg
60 mg
Social anxiety disorder
20 mg
20 mg
50 mg
Post-traumatic stress disorder
20 mg
20 mg
50 mg
Generalized anxiety disorder
20 mg
20 mg
50 mg
Most people start to feel better after a few weeks of treatment.If there is no improvement after this time, the patient should talk to their doctor, who will give them further advice.
The doctor may recommend gradually increasing the dose, by 10 mg at a time, up to the maximum daily dose.
The tablets should be taken in the morning, with food. The tablets should be swallowed whole, without chewing, with a glass of water.
The score line is to help break the tablet to make it easier to swallow, not to divide it into two equal doses.
The doctor will tell the patient how long they need to take the tablets. The treatment may last for several months or even longer.
If the patient is elderly (over 65 years old), the maximum daily dose is 40 mg per day.
Children and adolescents under 18 years oldshould not normally take Parogen, unless their doctor considers it to be in their best interest.
In cases of liver disease or severe kidney disease, the doctor may decide to prescribe a lower dose of Parogen than usual.
The patient should never take more tablets than their doctor has prescribed. If they have taken more Parogen tablets than prescribed (either intentionally or unintentionally), they should contact their doctor or go to the hospital immediately.
The patient should show the doctor the packaging of the tablets.
A person who has taken an overdose of Parogen may experience side effects listed in section 4 "Possible side effects" or symptoms such as vomiting, dilated pupils, fever, headache, uncontrollable muscle contractions, and rapid heartbeat.
The medicine should be taken every day at the same time.
If a dose is missed and the patient realizes it before going to bed, they should take the missed dose immediately. The next day, they should take the medicine as usual. If the patient realizes they have missed a dose in the night or the next day, they should skip the missed dose.
Withdrawal symptoms may occur, but they should go away after taking the next dose at the usual time. The patient should not take a double dose of Parogen to make up for a missed dose.
Parogen does not relieve symptoms immediately - all antidepressants take time to work. Some people may start to feel better after a few weeks, but for others, it may take longer. Some people taking antidepressants may feel worse before they start to feel better. The doctor should recommend a follow-up visit after a few weeks of starting treatment. If there is no improvement, the patient should tell their doctor.
The patient should not stop taking Parogen unless their doctor tells them to.
When stopping treatment with Parogen, the doctor will advise gradual reduction of the dose over a few weeks or months - this should help reduce the risk of withdrawal symptoms. One way to do this is to gradually reduce the dose of Parogen by 10 mg per week. Most people find that the withdrawal symptoms from Parogen are mild and go away by themselves within 2 weeks. In some people, these symptoms may be more severe or may last longer.
If withdrawal symptoms occurwhen stopping Parogen, the doctor may decide to reduce the dose more slowly. If the patient experiences severe withdrawal symptoms after stopping Parogen, they should contact their doctor. The doctor may recommend starting to take the tablets again and then stopping them more slowly. Even if withdrawal symptoms occur, it is still possible to stop taking Parogen.
Studies have shown that 3 out of 10 patients experience one or more withdrawal symptoms when stopping Parogen. Some withdrawal symptoms are more common than others.
If the patient is concerned about withdrawal symptoms when stopping Parogen, they should contact their doctor.
If the patient has any doubts about taking Parogen, they should consult their doctor or pharmacist.
Like all medicines, Parogen can cause side effects, although not everybody gets them.
The risk of side effects is higher in the first few weeks of taking Parogen.
Side effects with unknown frequency(frequency cannot be estimated from the available data):
Patient studies have shown an increased risk of fractures in patients taking this type of medicine.
In paroxetine studies in patients under 18 years old, common side effects (occurring in less than 1 in 10 patients) included increased thoughts of suicide and attempted suicide, self-harm, hostility, and aggression or oppositional behavior. These studies also showed that these symptoms occurred, although less frequently, in children and adolescents taking placebo (sugar pills) instead of paroxetine.
Additionally, in patients under 18 years old, common side effects (occurring in less than 1 in 10 patients) included abdominal pain, feeling irritable, and mood swings (including tearfulness and mood changes, self-harm, suicidal thoughts, and attempted suicide).
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
The medicine should be stored out of the sight and reach of children.
The patient should not use this medicine after the expiry date (EXP) stated on the bottle, blister, or carton. The expiry date refers to the last day of that month.
The medicine should not be stored above 25°C.
The medicine should be stored in its original packaging to protect it from light.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer need. This will help protect the environment.
The active substance is paroxetine.
Each coated tablet contains 20 mg of paroxetine in the form of anhydrous hydrochloride.
The other ingredients are:
tablet core: calcium hydrogen phosphate anhydrous, sodium carboxymethylcellulose (type A), colloidal silicon dioxide anhydrous, magnesium stearate. See section 2 "Parogen contains sodium".
tablet coating: talc, titanium dioxide (E171), Eudragit E100: butyl methacrylate, (2-dimethylaminoethyl) methacrylate, and methyl methacrylate copolymer (1:2:1).
Parogen 20 mg coated tablets are white tablets, with the inscription "P2" on one side and the inscription "G" on the other side, with a diameter of approximately 8 mm. The tablets have a score line on one side.
Parogen is available in polyethylene bottles and blisters containing 10, 12, 14, 20, 28, 30, 50, 56, 58, 60, 98, 100, 200, 250, or 500 tablets. The bottles contain a desiccant. The patient should not take the desiccant.
Not all pack sizes may be marketed.
Marketing authorization holder
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
DUBLIN
Ireland
Manufacturer
McDermott Laboratories Ltd.
Trading as Gerard Laboratories
35/36 Baldoyle Industrial Estate
Dublin 13
Ireland
Mylan Hungary Kft.
H-2900 Komárom
Mylan utca 1.
Hungary
To learn more about their condition, the patient can contact a patient support group or organization. The doctor can provide more information on this.
For more information about Parogen, the patient should contact the representative of the marketing authorization holder:
Tel: +48 22 54 66 400
Date of last revision of the leaflet:December 2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.